Background: microRNAs can repress the expression of target genes by destabilizing their mRNAs or by inhibiting their translation. Our previous findings suggested that miR-193a-3p inhibited the progression of NSCLC both in vitro and in vivo. However, the biological processes and molecular pathways through which this miRNA exerts its positive effects are unknown. Methods: To explore the molecular mechanisms by which miR-193a-3p inhibited NSCLC metastasis, we investigated the changes in the protein profile of SPC-A-1sci (highly metastatic) cells in response to the up-regulation of miR-193a-3p expression using a proteomics approach (iTRAQ combined with NanoLC−MS/MS). Changes in the profiles of the expressed proteins were verified using western blotting and were analyzed using the DAVID and STRING programs. Results: In the two replicated experiments, 4962/4946 proteins were identified, and the levels of expression of 4923/4902 proteins were quantified. In total, 112 of these proteins were differentially expressed. Among them, the up-regulated levels of expression of two of the 62 proteins with up-regulated expression (PPP2R2A and GSN) and the down-regulated levels of expression four of the 50 proteins with down-regulated expression (LMNB2, UHRF1, G3BP1, and HNRNPU) were verified using western blotting. The bioinformatics analysis revealed the interactions and signaling networks of these differentially expressed proteins. Conclusion: miR-193a-3p inhibited the metastasis of lung cancer cells by deregulating the expression of tumor-related proteins. These findings may improve the understanding of the molecular mechanisms underlying the metastatic-inhibitory effect of miR-193a-3p on lung cancer cells.
Introduction
Lung cancer is the most prevalent cancer in humans and is the leading cause of cancerrelated deaths worldwide [1] . Although diagnostic and treatment methods have recently markedly improved, the 5-and 10-year survival rates remain at <15% and <7%, respectively [2] . Lung cancer has the lowest survival outcomes due to the very high metastatic potential of these cancers. The majority of the mortalities due to lung cancers are attributable to tumor metastases [3] . Because the majority of lung cancer patients present with invasive, metastatic disease, it is vital to understand the molecular mechanisms underlying metastasis [4] .
In our previous study, the highly metastatic cell line SPC-A-1sci was isolated from its parental SPC-A-1 cell line after several cycles of in vivo selection in NOD/SCID mice [5] . Proteomic approaches, which enable relatively comprehensive global analyses, have been widely used in studying complex biological functions [6, 7] . The isobaric tags for relative and absolute quantitation (iTRAQ) method combined with nano liquid chromatography-mass spectrometry (NanoLC−MS/MS), which was developed for protein quantitation, is a highthroughput quantitative technique [8, 9] .
MicroRNAs (miRNA) are endogenous ~23-nucleotide non-coding RNA molecules that regulate the expression protein-coding genes through degradation of the target mRNAs or inhibition of protein translation [10, 11] . Emerging evidence shows that miRNAs are implicated in various biological processes, such as proliferation, apoptosis, cellular migration, and differentiation. It was demonstrated that dysregulation of miRNA expression caused abnormal gene expression in a variety of cancers [12, 13] . In the field of miRNA research, the most important step is identifying the multiple target genes of miRNAs. Computational programs have been applied to predict the targets of miRNAs. However, these computational programs have inherent limitations, such as not considering the evidence for functional targeting within the 5´-untranslated region and protein-coding region [14] [15] [16] and not adjusting the predictions according to the co-expression of an miRNA and a target, which has been proposed to be an effective way of improving the accuracy of predictions [17] , so that many of the predicted targets may be false and many genuine targets could be missed [18] .
In the present study, with the aim of improving the understanding of the underlying molecular mechanisms underlying the metastasis-inhibitory effect of miR-193a-3p on lung cancer, a strategy that combined iTRAQ with NanoLC−MS/MS was utilized to analyze the alterations in the protein profile of the lung adenosquamous carcinoma cell line SPC-A-1sci following miR-193a-3p treatment.
Materials and Methods

Cell lines and cell culture
The highly metastatic human lung-cancer cell line SPC-A-1sci was established in our laboratory during a previous study through in vivo selection of clones of the cell line SPC-A-1, which has a low metastatic potential, grown in NOD/SCID mice [5] . The NSCLC cell line SPC-A-1sci was cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Biowest, South America Origin), 100 U/mL penicillin (Sigma-Aldrich, St. Louis, MO), and 100 μg/mL streptomycin (Sigma-Aldrich) in a humid chamber at 37°C in 5% CO 2 .
Creation of stably transfected cell lines
The miRNA mimic and the negative control miRNA of hsa-miR-193a-3p and the lentiviral vector were purchased from the GenePharma Company. The sequence of the miRNA mimic was 5'-AACTGGCCTACAAAGTCCCAGT-3', and that of the miR-control was 5'-TTCTCCGAACGTGTCACGT-3'.
Stably transfected cell lines were generated by transfecting SPC-A-1sci cells with the miRNA mimic or the miR-control lentiviral vector. 
RNA Extraction and Quantitative Real-time PCR Assays
The total RNA was extracted from cultured cells using a mirVana™ miRNA isolation Kit (Ambion) according to the manufacturer's protocol. The concentration and purity of the RNA were determined using ultraviolet spectrophotometry using the Nanodrop 2000 system (Thermo, Japan). To evaluate the miR-193a-3p expression levels, quantitative real-time PCR was performed using TaqMan miRNA assay kits (Applied Biosystems) according to the manufacturer's instructions. U6 mRNA was used as an endogenous reference, and its levels were used for normalization.
Protein Preparation
Harvested cells were washed three times using ice-cold PBS and were disrupted using a cell lysis buffer (Pierce, Rockford, IL, USA) containing protease and phosphatase inhibitors for 45 min on ice, followed by centrifugation at 12000 ×g for 15 min at 4°C. Next, the protein concentrations was determined using a bicinchoninic acid (BCA) protein assay kit according to the manufacturer's instructions (Pierce, Rockford, IL). Bovine serum albumin (BSA) was used as the standard.
iTRAQ Labeling and High-pH RPLC Fractionation
The iTRAQ Reagent 4-Plex kit (Applied Biosystems, Foster City, CA) was used according to the manufacturer's protocol to label peptides. Equal amounts of protein (100 μg per sample) obtained from the stably transfected cell lines (SPC-A-1sci NC and SPC-A-1sci miRNA mimic lines) were labeled using iTRAQ labeling reagents 116 and 117, respectively. Briefly, the proteins in each sample were reduced using tris-(2-carboxyethyl) phosphine (TCEP) and were alkylated using methyl methane-thiosulfonate (MMTS). Afterward, the samples were digested overnight at 37 °C using trypsin (mass spectrometry grade, Promega, Madison, WI) at a trypsin:protein ratio of 1:20 (W/W). Then, the tryptic peptides were labeled using iTRAQ reagents. The iTRAQ-labeled samples were combined in a fresh tube, desalted using Oasis HLB cartridges (Waters, Milford, MA, USA) and dried using a vacuum centrifuge (Concentrator Plus, Eppendorf, Germany). The iTRAQ-labeled peptides were fractionated using an Agilent 1290 system using a Durashell C18 column (4.6×250 mm, 5 μm, 100 Å, Agela technologies, China) for high-pH RP chromatography. A total of 20 RP fractions were collected and were then desalted using C18 cartridges (UltraMicroSpin, The Nest Group, Southborough, MA), after which they were dried and were reconstituted using 20 μL of 0.1% FA for NanoLC− MS/MS analysis.
NanoLC−MS/MS Analysis
The RP fractions were analyzed in duplicate using NanoLC−MS/MS using a NanoLC system (NanoLC-2D Ultra, Eksigent, Dublin, CA) connected to a Triple TOF 5600 mass spectrometer (AB SCIEX, USA). Briefly, the peptides were enriched on an RP Trap column (ProteoPepIIC18 column, 5 μm, 300 Å, 0.15×25 mm, IntegraFrit, New Objective, Woburn, MA) and were then eluted onto an analytical column (ProteoPepC18 column, 5 μm, 300 Å, 0.075 ×150 mm, IntegraFrit, Woburn, MA) and were separated using a 120-min gradient of 5 to 35% Buffer B (98% ACN, 2% H2O, 0.1% FA) at a flow rate of 300 nL/min. The MS analysis was performed using a nano ion spray voltage that was typically maintained at 2.3 kV and a scan range of 350 to 1500 (m/z) in the positive-ion mode. Full-scan MS spectra were acquired from 40 precursors that had been selected for MS/MS from the m/z 100−1500 range using a dynamic exclusion setting of 30 s. The IDA CE parameter script, which selected up to 40 precursors with charge states of 2+ to 4+, automatically controlled the collision energy (CE). The mass spectrometer was calibrated using the tryptic peptides of a beta-galactosidase (BG).
Protein Identification and Quantitation
Analysis of the proteins was performed using ProteinPilot4.1 software (AB SCIEX, USA). The search parameters were as follows: (1) sample type, iTRAQ 4-plex (Peptide Labeled); (2) cysteine alkylation, MMTS; (3) digestion, trypsin; (4) instrument, Triple TOF5600; (5) special factors, none; (6) species, Homo sapiens; (7) ID Focus, biological modifications; (8) database, UniProtKB/Swiss-Prot FASTA (which was released in November, 2013 and consists of 176592 human sequences); and (9) search effort, Thorough ID. In the iTRAQ quantitation, the Pro Group algorithm had been automatically selected to calculate the reporter-peak areas. To estimate the FDR for peptide identification, a decoy database search strategy was adopted. For this study, a strict unused confidence score of >1.3 were used as the qualification criteria, which corresponded to Cellular Physiology and Biochemistry a peptide confidence level of 95%. If the iTRAQ ratios were >1.5 or <0.67 in the samples obtained from the highly metastatic SPC-A-1sci cells containing miR-193a-3p relative to those of the miR-control, the proteins were considered to be differentially expressed.
Western Blotting (WB)
Protein samples of the stably transfected cell lines SPC-A-1sci miR-control and SPC-A-1sci miRNA mimic were harvested. Twenty micrograms of protein/well was loaded on 8% gels for separation using sodium dodecyl sulfate-polyacrylamide gels electrophoresis (SDS-PAGE) and subsequent electroblotting onto NC membranes (Millipore, Billerica, MA, USA). The membranes were then blocked for one hour using 5 % nonfat dry milk in PBS-T (0.05 % Tween-20 in PBS). After blocking, the membranes were rinsed and were incubated with rabbit anti-PPP2R2A (1:100), rabbit anti-G3BP1 (1:500) and rabbit anti-UHRF1 (1:250) antibodies purchased from Proteintech TM ; rabbit anti-GSN (1:500) antibodies purchased from Cell Signaling Technology and rabbit anti-HUNRNPU (1:50) antibodies purchased from Abcam; mouse anti-LMNB2 (1:20) antibodies purchased from Santa Cruz Biotechnology. HRP-conjugated anti-goat IgG (1:20000) purchased from Sigma-Aldrich was used as a secondary antibody for an incubation period of 1 h. The labeled bands were visualized using the SuperSignal West Femto Maximum Sensitivity Substrate (Thermo, Japan), and the β-actin levels were used as the loading controls.
Data Analysis STRING (http://string.embl.de) is a database of predicted signaling networks and protein interactions. Ontological analysis of the dysregulated genes was performed using the search tool DAVID (http://david. abcc.ncifcrf.gov/).
Statistical Analysis
The levels of miR-193a-3p expression, determined using real-time PCR, and the differences in the protein profiles of the groups of cells were compared using the t-test, using SPSS 19.0 software. A P-value of less than 0.05 was considered significant.
Results
Comparative Proteomics of SPC-A-1sci miRNA mimic Cells versus SPC-A-1sci miR-control Cells
We created stably transfected cell lines by transfecting SPC-A-1sci cells with the miRNA mimic/miR-control lentiviral vectors. The extracted RNA was used to detect the levels of miR-193a-3p expression (Fig. 1A) . The proteins were extracted from the two cell lines. The samples were digested using trypsin and labeled using the 116 and 117 iTRAQ tags, respectively. The labeled digests were utilized for MS analysis (Fig. 1B) . Using ProteinPilot 4.1, we identified a total of 6127/6118 proteins in these two cell lines (global FDR of < 1%). Using the filters of an unused protein score of >1.3 and a number of peptides of ≥2, 4962/4946 proteins were identified and the amounts of 4923/ 4902 proteins were quantified. The labelling rate was 99.2% (4923/4962) and 99.1% (4902/4946) in the two runs (Table 1) . In total, we identified 62 up-regulated (with 117:116 iTRAQ ratios of > 1.5 in the two runs) and 50 down-regulated proteins (with 117:116 iTRAQ ratios of < 0.67 in the two runs) in SPC-A-1sci miRNA mimic cells compared with the SPC-A-1sci miR-control cells (Fig. 1C and Tables 2 and 3 ). 
Cluster Analysis of the miR-193a-3p-regulated Proteins
The heatmap contains the data obtained for the 112 dysregulated proteins. The two horizontal clusters represent the technical replicates. The clustering of the globally dysregulated proteins in the miR-193a-3p-overexpressing cells may provide direct evidence that the genes encoding these differentially expressed proteins are regulated by miR-193a-3p (Fig. 2) .
Evaluation of iTRAQ Results using Western Blotting
Based on the results of the MS analysis, the levels of expression of six of the dysregulated proteins was validated using western blotting analysis of proteins of the SPC-A-1sci mir193a-3p mimic cells and the SPC-A-1sci miRNA negative control cells. The expression levels of four proteins (HNRNPU, G3BP1, UHRF1, and LMNB2) were down-regulated (Fig. 3A) and the expression levels of two proteins (PPP2R2A and GSN) were up-regulated (Fig. 3B) , which was consistent with the results of the MS analysis. Therefore, the expression levels of 112 proteins were considered to be regulated by miR-193a-3p.
Functional Enrichment of the miR-193a-3p-regulated Proteins
Some of the proteins among the globally dysregulated group have been reported to be involved in lung cancer; for example, UHRF1, G3BP1 and KRT7 were associated with lung cancer metastasis and PSAT1, PRKDC and PPP2R2A were associated with lung-cancer cell proliferation. To further elucidate the biological processes affected by miR-193a-3p expression, these differentially expressed proteins were applied to the DAVID database to achieve an enrichment analysis regarding involvement in a biological process, a cellular component or a molecular function (Fig. 4) .
Analysis of the signaling network
We uploaded the globally dysregulated proteins after stably transfecting the miR-193a-3p and their names into the STRING database. Ninety-four proteins were identified by the The proteins of the cell lines that were stably transfected with the miR-control and the miR-mimic were digested with trypsin and were labeled using 116/117 ITRAQ tags, respectively. The labeled digests were separated using offline SCX LC and were analyzed using Nano LC-MS/MS. The differentially expressed proteins were evaluated using western blotting and were analyzed through database searches. (C) In total, 112 proteins were identified, including 62 up-regulated proteins and 50 down-regulated proteins, in two physical replicates. database, whereas 24 proteins did not show any link at the chosen confidence level (STRING score=0.4). A merged network is shown in Fig. 5 . The most significant functions of the proteins in the network were cytoskeletal organization, RNA transport, RNA processing and protein localization. KHSRP, RANBP2, XPO1, LRPPRC and TPR are important proteins in RNA transport. DDX23, DHX9, KHS-RP, SSB, HNRNPR and HNRNPU are important proteins in the RNA metabolic process. ACTN4, GSN, KRT19, KRT8 and PAFAH1B1 are associated with cytoskeletal organization. The program predicted associations for a particular group of proteins.
Discussion
In a previous study, we demonstrated that miR-193a-3p was involved in metastasis of NSCLC cells. Overexpression of miR-193a-3p suppressed the migration and invasion of NSCLC cells in vitro and NSCLC metastasis in vivo through down-regulating the expression of ERBB4 and S6K2 [19] . However, the complex cancer inhibitory mechanisms 
underlying the effects of this small non-coding RNA and the molecular targets through which miR-193a-3p acts have not yet been fully determined. In this study, the lung adenocarcinoma cancer cell line SPC-A1sci, which was established by our laboratory and which has a highly metastatic potential, was used as a model, and the isobaric tags for relative and absolute quantitation (iTRAQ) approach combined with nano liquid chrom a to g ra p hy-t a n d e m mass spectrometry (NanoLC−MS/MS) analysis were used to identify the proteins species with altered levels of expression in the SPC-A-1sci cells that overexpressed miR-193a-3p. The proteomic analysis revealed a total of 112 dysregulated protein species, the functions of which were involved in diverse biological processes, such as protein transport, RNA processing, cytoskeletal organization and translation. Among these proteins, 62 proteins exhibited up-regulated expression and 50 proteins exhibited down-regulated expression. The oncoproteins with miR-193a-3p-dysregulated expression are thought to be associated with the inhibition of NSCLC progression.
GSN and PPP2R2A were up-regulated by miR-193a-3p. Gelsolin (GSN) is a cytoskele- [21] . In contrast, GSN expression is frequently down-regulated in ovarian, stomach and colon cancers [22] [23] [24] . In our study, the up-regulation of GSN expression may play a role in inhibiting the metastasis of SPC-A1sci cells transfected with miR-193a-3p. PPP2R2A is a candidate tumor-suppressor gene that is implicated in the negative control of cell growth and division because it is a member of the protein phosphatase 2 (PP2A) regulatory subunit B family [25] . Many studies have reported that PPP2R2A down-regulation was observed in acute myelogenous leukemia and prostate adenocarcinoma, as well as in lung cancer [26] [27] [28] .
The proteins with down-regulated expression mediated by the overexpression of miR193a-3p are UHRF1, G3BP1, LMNB2 and HNRNPU.
UHRF1 belongs to the UHRF family and is a nucleoprotein involved in cell growth and proliferation [29] . It was found that UHRF1 could promote the G1/S transition as a direct target of E2F1, which is a transcriptional factor essential for S-phase entry [30] . In examining many human cancers, including lung cancer, breast cancer and colorectal cancer [31] [32] [33] , we have found that UHRF1 could promote their proliferation and metastasis.
G3BP1 is one member of the G3BP family that participates in several signaling pathways involved in carcinogenesis. G3BP1, which was reported to be highly overexpressed in various cancers, including breast cancer, esophageal squamous carcinoma and lung cancer [34] [35] [36] , was found to be closely associated with the invasion and metastasis of tumor cells.
LMNB2 is a component of the nuclear lamina, which is the intermediate-filament 
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry meshwork lying beneath the inner nuclear membrane [37] . HNRNPU, which plays an important role in the processing and transport of mRNA, is the largest member of the hnRNP protein family [38] . LMNB2 and HNRNPU had not been reported in lung cancer progression. They might be new targets of miR-193a-3p-mediated inhibition of SPC-A-1sci migration. In summary, we used the iTRAQ quantitative approach combined with nano liquid chromatography-tandem mass spectrometry analysis to identify the proteins species with altered levels of expression in SPC-A-1sci cells overexpressing miR-193a-3p. Our findings may improve the understanding of the molecular mechanisms underlying the metastasisinhibitory effects of miR-193a-3p on lung cancer cells. 
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